Measuring Ultrasound Guided Skeletal Muscle Mass of Lower Extremity as a Predictor of Post-Operative Length of Stay in Exploratory Gynae-oncology Surgeries
Recruiting now
Conditions studied: Gynecologic Cancer, Frailty, Sarcopenia
In brief
Increased incidence of Gynae-oncological cancer is observed specifically in women above 50 years of age. Sarcopenia (a progressive and generalized loss of skeletal muscle mass, quality, and strength) is considered a reliable indicator of frailty, a poor prognostic factor in these patients. Various frailty scores and measurement of psoas muscle mass are time consuming, can't be done in patients unable to walk and altered mental status. The investigators wanted to evaluate if bedside ultrasound guided skeletal muscle measurement, as a measure of sarcopenia, can be used to predict post operative length of stay.
Key facts
- Study ID
- NCT06816836
- Run by
- Tata Medical Center
- People needed
- 320
- Starts
- 2025-04-01
- Expected to finish
- 2027-09-30
- Last updated by the study team
- 2025-05-29
Who can join
Age: 50 and older, up to 99. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- All consecutive consenting patients above 50 years of age, having a Charlson Comorbidity Index score of 3 or more, undergoing open surgeries for GCs.
You may not qualify if…
- A. Refusal of consent B. Patients with psychiatric illnesses who are unable to follow instructions. C. Patients below the age of 50 years. D. Patients with known neuromuscular disorders. E. Patients in whom contrast-enhanced CT scan of the abdomen and pelvis is not done.
- F. Previous major surgery of limbs (Amputation, Hip surgeries/ long bone surgeries)
Where it is running
- Tata Medical Center — Kolkata, West Bengal, India (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.